Natural Product: NPC474388

Natural Product IDNPC474388
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Rhamnazin Triacetate
IUPAC Name [4-(3,5-diacetyloxy-7-methoxy-4-oxochromen-2-yl)-2-methoxyphenyl] acetate
Synonyms Rhamnazin Triacetate
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL465819
PubChem CID 44584491
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0002585] O-methylated flavonoids
          • [CHEMONTID:0002592] 7-O-methylated flavonoids

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LODXNGWSMYYFFA-UHFFFAOYSA-N
Standard InCHI InChI=1S/C23H20O10/c1-11(24)30-16-7-6-14(8-17(16)29-5)22-23(32-13(3)26)21(27)20-18(31-12(2)25)9-15(28-4)10-19(20)33-22/h6-10H,1-5H3
SMILES COc1cc(OC(=O)C)c2c(c1)oc(c(c2=O)OC(=O)C)c1ccc(c(c1)OC)OC(=O)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   456.11 Volume:   439.596
?
Van der Waals volume.
Dense:   1.038 LogP:   2.105
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.486
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.719
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   21.0
TPSA:   127.57
?
Topological Polar Surface Area.
H-Bond Acceptor:   10.0
H-Bond Donor:   0.0 Rings:   3.0
Heavy Atoms:   10.0

MedChem Properties

QED Drug-Likeness Score:   0.403 GASA:   0.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   2.579 Fsp3:   0.217
MCE-18:   22.0
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.023 Fluc inhibitor:   0.327
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.989
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.787
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.341 Promiscuous compounds:   0.246

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -4.707 MDCK Permeability:   -4.383
Pgp-inhibitor:   0.999 Pgp-substrate:   0.005
PAMPA:   0.006
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.095
20% Bioavailability (F20%):   0.035 30% Bioavailability (F30%):   0.718
50% Bioavailability (F50%):   0.94

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.003 MRP1:   0.268
Plasma Protein Binding (PPB):   85.287% Volume Distribution (VD):   -0.197
Fu: 18.107%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.999
OATP1B3 inhibitor:   1.0 BCRP inhibitor:   0.05
BSEP inhibitor:   1.0

ADMET: Metabolism

CYP1A2-inhibitor:   0.422 CYP1A2-substrate:   0.999
CYP2C19-inhibitor:   0.128 CYP2C19-substrate:   0.923
CYP2C9-inhibitor:   0.019 CYP2C9-substrate:   0.017
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.034
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.0
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.973
HLM stability:   0.994
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.173 Half-life (T1/2):  0.443

ADMET: Toxicity

hERG Blockers:  0.005 hERG Blockers (10um):  0.106
Human Hepatotoxicity (H-HT):  0.357 Drug-induced Liver Injury (DILI):  0.985
AMES Toxicity:  0.54 Rat Oral Acute Toxicity:  0.691
Maximum Recommended Daily Dose:  0.244 Skin Sensitization:  0.903
Carcinogencity:  0.237 Eye Corrosion:  0.704
Eye Irritation:  0.906 Respiratory Toxicity:  0.226
Drug-induced Neurotoxicity:  0.143 Ototoxicity:  0.058
Hematotoxicity:  0.674 Drug-induced Nephrotoxicity:  0.021
Genotoxicity:  0.769 RPMI-8226 Immunitoxicity:  0.03
A549 Cytotoxicity:  0.775 Hek293 Cytotoxicity:  0.161
BCF:   0.763
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.813
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.849
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.546
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33118 Rhamnus Genus Rhamnaceae Eukaryota n.a. n.a. n.a. PMID[8350094]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT20967 Cell line Platelet n.a. Activity = 10.0 % PMID[8350094]
NPT20967 Cell line Platelet n.a. Activity = 14.3 % PMID[8350094]
NPT20967 Cell line Platelet n.a. Activity = 84.5 % PMID[8350094]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC474388 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9615 High Similarity NPC474170
0.8727 High Similarity NPC472535
0.8704 High Similarity NPC177839
0.7778 Intermediate Similarity NPC310259
0.7193 Intermediate Similarity NPC605569
0.7143 Intermediate Similarity NPC474037
0.6833 Remote Similarity NPC608137
0.6429 Remote Similarity NPC72452
0.6316 Remote Similarity NPC602291
0.629 Remote Similarity NPC34725
0.6024 Remote Similarity NPC475434
0.5902 Remote Similarity NPC70853
0.5862 Remote Similarity NPC61546
0.5833 Remote Similarity NPC259058
0.5823 Remote Similarity NPC475214
0.5738 Remote Similarity NPC90582
0.5738 Remote Similarity NPC299923
0.5714 Remote Similarity NPC605582
0.5625 Remote Similarity NPC179126
0.5625 Remote Similarity NPC261548
0.5522 Remote Similarity NPC122623
0.5476 Remote Similarity NPC476180
0.5385 Remote Similarity NPC236769
0.5362 Remote Similarity NPC241774
0.5152 Remote Similarity NPC104459
0.5139 Remote Similarity NPC257277
0.5075 Remote Similarity NPC279930
0.5075 Remote Similarity NPC131557

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474388 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data